4,83 €
3,31 % vorgestern
L&S, 30. Januar, 22:53 Uhr
ISIN
CA0717341071
Symbol
BHC
Berichte

Bausch Health Companies Inc. Aktie News

Negativ
Reuters
9 Tage alt
Bausch Health said on Friday its treatment to prevent brain dysfunction in patients with liver cirrhosis did not meet the main goal of a late-stage trial.
Neutral
PRNewsWire
9 Tage alt
LAVAL, QC, Jan. 23, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced the results of the global Phase 3 RED-C clinical program evaluating amorphous-rifaximin solid soluble dispersion (SSD) in adults with liver cirrhosis for the primary prevention of hepatic encephalopathy (HE). While safe and well-tolerated, both clinical trials did not meet the primary endp...
Neutral
PRNewsWire
11 Tage alt
LAVAL, QC, Jan. 21, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release fourth quarter and full year 2025 financial results after market close on Wednesday, February 18, 2026. Bausch Health will host a live conference call and webcast at 5:00 p.m.
Neutral
Seeking Alpha
17 Tage alt
Bausch Health Companies Inc. (BHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neutral
PRNewsWire
27 Tage alt
LAVAL, QC, Jan. 5, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that Thomas J. Appio, Chief Executive Officer, will participate at the 44th Annual J.P.
Positiv
24/7 Wall Street
etwa ein Monat alt
Dan Loeb of Third Point is a brilliant investor worth watching closely whenever the 13F filings roll in.
Neutral
Accesswire
etwa ein Monat alt
LAVAL, QC / ACCESS Newswire / December 23, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company") and its subsidiary 1261229 B.C. Ltd. (the "Issuer" and, together with the Company, the "Offerors") today announced the final results and expiration of their previously announced offers to exchange the Company's outstanding 4.875% Senior Secured Notes due 2028 (the "4.875% Notes") a...
Negativ
The Motley Fool
etwa 2 Monate alt
Lombard Odier Asset Management (USA) Corp sold 3,334,000 shares of Bausch Health Companies; position value declined by approximately $22,564,800 Change represents approximately 1.53% of Lombard Odier Asset Management (USA) Corp's reportable U.S. equity assets Post-trade holding: 1,716,000 shares valued at approximately $11,068,200 The position now represents approximately 0.74% of fund AUM, pla...

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen